Svas Biosana S.p.A. (BIT:SVS)

Italy · Delayed Price · Currency is EUR

8.72

+0.22 (2.59%)

At close: Jul 27, 2026

6.08% (1Y)

Market Cap	45.54M +4.3%
Revenue (ttm)	141.56M +15.8%
Net Income	6.77M +15.2%
EPS	1.29 +17.3%
Shares Out	5.22M
PE Ratio	6.74
Forward PE	6.87
Dividend	0.25 (2.94%)
Ex-Dividend Date	Jun 1, 2026

Volume	920
Open	8.62
Previous Close	8.50
Day's Range	8.62 - 8.72
52-Week Range	7.68 - 10.80
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About Svas Biosana

Svas Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels for use in medical fields.In addition, the company provides specialist medical devices for use in oncology, intensive care, chronic diseases, and surgeries; and medic... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1972

Employees 348

Stock Exchange Borsa Italiana

Ticker Symbol SVS

Full Company Profile

Financial Performance

In 2025, Svas Biosana's revenue was 141.56 million, an increase of 15.76% compared to the previous year's 122.29 million. Earnings were 6.77 million, an increase of 15.24%.

Financial Statements